265 results on '"FASULO, Vittorio"'
Search Results
2. A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer
3. Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study
4. Inter-reader Agreement for Prostate Cancer Detection Using Micro-ultrasound: A Multi-institutional Study
5. Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken
6. Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer
7. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
8. Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy.
9. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy
10. Development of a microultrasound-based nomogram to predict extra-prostatic extension in patients with prostate cancer undergoing robot-assisted radical prostatectomy
11. Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study
12. MP31-03 DECODING CLINICALLY SIGNIFICANT PROSTATE CANCER IN BIOPSY NAIVE PATIENTS: A MACHINE LEARNING APPROACH FROM A TERTIARY REFERRAL CENTER
13. PD13-12 DIAGNOSTIC PERFORMANCE OF MICROULTRASOUND AT CONFIRMATORY RECLASSIFICATION BIOPSY IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
14. PD45-07 EXTERNAL VALIDATION OF THE AMSTERDAM-BRISBANE-SYDNEY NOMOGRAM FOR THE PREDICTION OF LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS SUBJECTED TO RADICAL PROSTATECTOMY AND CONCOMITANT LYMPH NODE DISSECTION
15. MP16-01 REPLACING RETUR WITH CYSTOSCOPY IN HIGH-GRADE T1 NMIBC PATIENTS: CONFIRMATORY RESULTS FROM THE HUNIRE TRIAL
16. MP49-15 EVALUATING THE ROLE OF PRI-MUS PROTOCOL IN IDENTIFYING CLINICALLY SIGNIFICANT PROSTATE CANCER: A HIGH-VOLUME EXPERIENCE ON MICROULTRASOUND
17. PD19-12 THE ROLE OF PSMA PET/CT IN PREDICTING PATHOLOGICAL LOCAL STAGING AND GRADING FOR PROSTATE CANCER
18. MP22-13 FRAILTY ADAPTED ERAS PATHWAY FOR PATIENTS WITH BLADDER CANCER REQUIRING SURGERY: THE GLOBAL RADICAL CYSTECTOMY EVALUATION AND MANAGEMENT (GRACEM) STUDY PROTOCOL
19. MP67-03 IMPACT OF NUMBER OF INNER AND OUTER RENORRAPHY STITCHES ON FUNCTIONAL OUTCOMES AFTER ROBOTIC ASSISTED PARTIAL NEPHRECTOMY
20. MP67-11 PREDICTIVE FACTORS OF 60 DAYS DISEASE PERSISTENCE AND 6-12 MONTHS RECURRENCE AFTER MICROWAVE ABLATION TREATMENT FOR SMALL RENAL MASSES: A SINGLE-CENTER INSTITUTIONAL PROSPECTIVE ANALYSIS
21. PD33-04 OFF-CLAMP VERSUS ON-CLAMP ROBOT-ASSISTED PARTIAL NEPHRECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS
22. MP74-08 [68GA]PSMA PET/CT VS. MPMRI IN PATIENTS WITH SUSPICION OF PROSTATE CANCER AND PREVIOUS NEGATIVE BIOPSY: RESULTS OF THE PROSPET-BX TRIAL
23. MP19-13 WHAT HAPPENS TO PATIENTS WITH A PI-RADS 5 LESION AND A NEGATIVE PROSTATE BIOPSY? LONG TERM FOLLOW UP OF A SINGLE INSTITUTIONAL EXPERIENCE
24. Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis
25. Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
26. Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken
27. Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy:Optimizing the Number of Cores Taken
28. Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy.
29. Preliminary findings on vitamin D 25‐OH levels in urine analysis: implications for clinical practice.
30. Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project
31. Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center.
32. Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?
33. Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes
34. Clinical and pathological predictors of persistent T1 HG at second resection
35. Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve vesical neoplasms: Interim analysis.
36. Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
37. Imaging predictive biomarkers of response in patients with prostate cancer undergoing high-intensity focused ultrasound (HIFU) focal therapy.
38. Interim analyses from the PROSPET-BX trial: [ G8 Ga]PSMA PET/CT vs. mpMRI in patients with suspicion of prostate cancer and previous negative biopsy.
39. Assessing the mid-term impact of enhanced prostate cancer screening in Caucasian men with germline DNA repair pathogenic variants.
40. A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program.
41. Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer
42. Diagnostic performance of microUltrasound at MRI‐guided confirmatory biopsy in patients under active surveillance for low‐risk prostate cancer
43. MP73-16 SUV VARIATION ON PSMA PET/CT CORRELATES WITH BIOCHEMICAL RESPONSE IN PATIENTS WITH PROSTATE CANCER UNDERGOING HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOCAL THERAPY
44. MP80-13 IMPACT OF A STRUCTURED REHABILITATION PROGRAM ON THE FUNCTIONAL OUTCOMES OF PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A SINGLE TERTIARY-CARE CENTER EXPERIENCE
45. MP55-04 THE PREOPERATIVE USE OF MICROUS TO DETECT EXTRAPROSTATIC EXTENSION OF PROSTATE CANCER: AN UPDATE OF A SINGLE INSTITUTIONAL PROSPECTIVE SERIES
46. MP55-03 CORRELATION BETWEEN PSMA PET/CT DATA AND PATHOLOGICAL TUMOUR STAGING AND GRADING OF PROSTATE CANCER
47. MP14-11 SINGLE CELL-BASED IMMUNE PROFILING OF THE TUMOR AND ITS IMMUNE MICROENVIRONMENT REVEALED DIFFERENCES BETWEEN NMIBC AND MIBC: IMPLICATION FOR IMMUNO-THERAPY
48. MP40-17 CLINICAL AND HIGH-RESOLUTION MICRO-ULTRASOUND RISK FACTORS FOR DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH PI-RADS 3 LESIONS: UPDATE FROM A LARGE SINGLE CENTER EXPERIENCE
49. MP55-19 MICRO-ULTRASOUND GUIDED PROSTATE BIOPSIES: EXPERIENCE FROM A HIGH-VOLUME CENTER
50. MP55-15 IS MICROULTRASOUND A RELIABLE TOOL FOR PROSTATE CANCER DIAGNOSIS? RESULTS FROM A SINGLE-INSTITUTION COHORT OF OVER 1,000 MEN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.